Placeholder Banner

BIO Congratulates SAB Biotherapeutics on Pharm Groundbreaking

October 5, 2017

“The health of humans, animals and the environment are inextricably connected,” said Dan Jenkins, Senior Director for Food & Agriculture, Biotechnology Innovation Organization (BIO). “Understanding this connectivity – and how biotechnology helps to heal, fuel and feed the world – can help the global community prevent and cure illness and disease.”

One example of this biological connectedness is SAB’s work with transgenic cattle to produce human antibody immunotherapies.

“SAB’s platform can produce antibodies targeting cancer, autoimmune disorders, inflammation, and infectious diseases,” explained Dr. Eddie Sullivan, SAB President, CEO and Co-founder. “Part of our vision to address emerging infectious disease threats is leveraging a dedicated herd of human antibody producing cattle to be readily available in the event of an outbreak.”

The 80-acre pharm under construction, an agricultural-based production unit whose output is biopharmaceuticals for the benefit of human health, is the first facility of its kind designed specifically for cattle.

“Animal biotechnology holds immense promise in improving not just human health, but also enhancing animal and environmental health as well, a prime example of the ‘One Health’ concept,” said Jenkins, who attended the groundbreaking ceremony. “Breaking down barriers that inhibit innovation are important steps towards achieving improved global health.” 

Discover More
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…